[The treatment of chronic alveolar hypoventilation (not including physiotherapy and artificial ventilation) (author's transl)].
D015765:Almitrine; D001993:Bronchodilator Agents; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004315:Doxapram / Q000627:therapeutic use; D004599:Electric Stimulation Therapy; D006371:Helium / Q000008:administration & dosage; D006801:Humans; D007040:Hypoventilation / Q000628:therapy*; D008525:Medroxyprogesterone / Q000627:therapeutic use; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010791:Phrenic Nerve; D010879:Piperazines / Q000627:therapeutic use; D011650:Pulmonary Alveoli / Q000503:physiopathology; D012138:Respiratory Therapy; D012459:Salicylates / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use
D001993:Bronchodilator Agents; D002257:Carbonic Anhydrase Inhibitors; D000697:Central Nervous System Stimulants; D000451:Mineralocorticoid Receptor Antagonists; D010879:Piperazines; D012459:Salicylates; D014227:Triazines; D006371:Helium; D004315:Doxapram; D015765:Almitrine; D013806:Theophylline; D008525:Medroxyprogesterone
Le traitement de l'hypoventilation alvéolaire chronique (kinésithérapie et ventilation artificielle exclues).